Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
For pharmaceutical companies without their own facilities, choosing the right partner for latephase clinical trials and commercial production is a critical consideration in developing parenteral products. Small contract development and manufacturing organizations (CDMOs) can often provide early-phase material but may not always be able to move through to meet the rigorous demands of late stage and into commercialization. This article examines some of the key criteria for selecting the right CDMO partner and includes a case study that shares some challenges involved in a late-phase technology transfer for a parenteral product.